The global antibody drug conjugates market size was US$ 4,990.8 million in 2021. The global antibody drug conjugates s market size is forecast to reach US$ 33,150.3 million by 2030, growing at a CAGR of 26.7% during the forecast period from 2022 to 2030.
Request To Download Free Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=Pol839
Antibody-drug Conjugates, also known as ADCs, are biopharmaceutical therapies that combine monoclonal antibodies specific to surface antigens found on specific tumor cells with highly effective anti-cancer medications joined via a chemical linker.
Factors Influencing Market Growth
Among the factors driving the global market include the rising incidence of cancer, the increasing geriatric population, changing in lifestyle patterns globally.
The strict government restrictions and a surge in the cost of procedures, and lack of funds may slow down the overall market growth.
The growing research activities on antibody therapies, preclinical research, more research on advanced drug discoveries, and rising research on oncology diseases, and the increasing collaboration between research institutes, Biotechnology, and Biopharmaceuticals companies are forecast to offer lucrative growth in the market during the forecast period.
Impact Analysis of COVID-19
The COVID-19 pandemic has had a negative impact on the global antibody drug conjugates market. Several governments imposed a lockdown in order to curb the spread of the deadly virus. As a result, hospitals and care services had to reduce and focus on the COVID-19 patients. The American Cancer Society data indicates there was a 52% reduction in the diagnosis of breast cancer in 2021, whereas a 25% of reduction in the diagnosis of pancreatic cancer was felt in March and April 2020. Due to the decline in the diagnosis of cancer incidences, the global market demand declined. In addition, cancer patients were at increased risk of developing severe difficulties following SARS-CoV-2 virus infection. Thus, the COVID-19 pandemic had a negative impact on the global market growth.
Regional Insights
North America held dominance in the market and accounted for the major revenue share in 2020. As a result of the rising awareness about current therapies, the existence of major players, a high majority of cancer patients, and effective R&D expenditure.
Europe is forecast to have lucrative growth in the market during the forecast period. Among the factors driving the market include growing incidences of cancer, a rising geriatric population, and increasing investments in research and development. The increased cancer incidence indicates the requirement to adopt novel therapies like antibody-drug conjugates that effectively decrease the burden. Thus, this factor is forecast to drive market growth in the region.
Get a Free Sample PDF copy of the report @https://reportocean.com/industry-verticals/sample-request?report_id=Pol839
Leading Competitors
The leading prominent companies profiled in the global antibody drug conjugates market are:
Novartis AG
Takeda Pharmaceutical Company Limited
F. Hoffman-La Roche Limited
Pfizer, Incorporated
Seattle Genetics Incorporated
Genentech Inc.
Immunogen Inc
Progenics Pharmaceuticals Inc
Immunomedics, Inc.
Bayer Healthcare Pharmaceuticals.
Agensys, Inc.
Concortis Biotherapeutics
Celldex Therapeutics Inc.
Sanofi S.A.
Synthon Holding B.V.
Other Prominent Players
The report furnishes an intricate comprehension of each segment, delivering potential estimations for principal applications and insights into emerging prospects. Every regional market is meticulously scrutinized to ascertain its potential for growth, development, and demand in the forthcoming years.
As of the end of 2022, the Antibody Drug Conjugates industry experienced notable growth in its workforce. Starting in January, employment within the Antibody Drug Conjugates sector exceeded its pre-COVID levels, resulting in an expansion of payrolls by over 15,000 employees throughout the course of the year. The global Antibody Drug Conjugates output demonstrated a remarkable increase of 5.2% during 2021, primarily attributed to a widespread economic upswing and a surge in demand for commodities. However, the momentum shifted in 2022, with the global industrial sector’s production contracting. This reversal followed a robust expansion in 2021, fueled by altered consumer spending patterns and substantial fiscal support.
Forecasts indicate that the global Antibody Drug Conjugates output is set to rise by approximately 2.9% in 2023. This projection is underpinned by the gradual recovery of production in Western Europe from its previous troughs, as well as a rebound in output across the Asia/Pacific region. Maintaining its dominant position, China, accounting for nearly 45% of the global Antibody Drug Conjugates market, remains both its largest producer and consumer. Remarkably, China’s market share has surged since 2010, when it stood at around 26%. This ascent has led to a substantial contribution to the nation’s GDP. Notably excelling as a top exporter, China leads in various sectors, including silicon, PVC, and several specific segments of the Antibody Drug Conjugates market.
Scope of the Report
The global antibody drug conjugates market segmentation focuses on Product Type, Technology, Target Type, Application, End-Users, and Region.
Segmentation based on Product Type
Adcetris
Kadcyla
Other Product Type
Download Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report ) @https://reportocean.com/industry-verticals/sample-request?report_id=Pol839
Segmentation based on Technology
Cleavable Linker
Non-Cleavable Linker
Segmentation based on Target Type
CD30 Antibodies
HER2 Antibodies
Other Target Types
Segmentation based on Application
Blood Cancer
Breast Cancer
Ovary Cancer
Lung Cancer
Skin Cancer
Brain Tumor
Other Applications
Segmentation based on End-User
Hospitals and Speciality Cancer Centers
Other End Users
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
Get The Insights You Need By Customizing Your Report To Fit Your Unique Needs And Goals:-https://reportocean.com/industry-verticals/sample-request?report_id=Pol839
Table of Contents:
Chapter 1: Introduction to the Global Antibody Drug Conjugates Industry
Chapter 3: Dynamics of the Market
Chapter 4: Profiles of Leading Companies
Chapter 5: Competition in the Global Antibody Drug Conjugates Market among Players
Chapter 6: Market Size across Global Regions
Chapter 7: Application Segments in the Global Market
Chapter 8: Segment Analysis of the Global Antibody Drug Conjugates Industry
Chapter 9: Market Chain, Sourcing Strategies, and Downstream Buyers
Chapter 10: Strategies and Key Policies by Distributors/Suppliers/Traders
Chapter 11: In-depth Analysis of Key Marketing Strategies by Market Vendors
Chapter 12: Evaluation of Market Impact Factors
Chapter 13: Forecasted Global Antibody Drug Conjugates Market Size (2023-2031)
Reasons to Acquire This Report
(A) This research imparts invaluable insights tailored for senior management, policymakers, industry professionals, product innovators, sales executives, and stakeholders within the market. It equips them with the information needed to make well-informed decisions and craft effective strategies.
(B) The report delivers a comprehensive analysis of global, regional, and country-level Antibody Drug Conjugates market revenues, extending projections until 2030. This dataset empowers companies to gauge their market presence, recognize avenues for growth, and explore emerging markets.
(C) Through meticulous segmentation of the Antibody Drug Conjugates market encompassing types, applications, technologies, and end-uses, this study empowers leaders to blueprint their products and allocate resources based on the projected growth trajectories of each segment.
(D) Investors stand to gain from the market analysis by gaining insights into market scope, positioning, key drivers, challenges, limitations, expansion prospects, and potential risks. Armed with this knowledge, they can make well-considered investment choices.
(E) The report conducts an intricate analysis of competitors, unraveling their pivotal strategies and market positioning. This intelligence equips businesses with a profound understanding of the competitive landscape, enabling them to chart their own strategies accordingly.
(F) The study facilitates the assessment of Antibody Drug Conjugates business projections delineated by region, key countries, and prominent companies, bestowing invaluable information for investment strategizing and decision-making.
Why is our study consequential?
Our study holds paramount importance for various reasons, a few of which include:
* Assisting businesses in gauging the viability of new or existing products or services.
* Facilitating business enterprises in the identification and cultivation of novel market segments.
* Providing a preemptive understanding of consumer demand prior to introducing new products, services, or features.
* Enhancing the overall efficacy of marketing, advertising, and promotional initiatives.
* Analyzing market trends to aid businesses in devising adaptive strategies.
* Guiding businesses in the optimal placement of their products.
Access Full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=Pol839
About Report Ocean:
Report Ocean is a renowned provider of market research reports, offering high-quality insights to clients in various industries. Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing their market share in today’s competitive environment. As a trusted source for innovative market research reports, Report Ocean serves as a comprehensive solution for individuals, organizations, and industries seeking valuable market intelligence.
Contact Information:
Email:[email protected]
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, United States
Telephone: +1 888 212 3539 (US – Toll-Free)
For more information and to explore their offerings, visit their website at:https://www.reportocean.com/
